PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Expanded Access IND Cleared by US FDA, page-4

  1. 92 Posts.
    lightbulb Created with Sketch. 10
    Listening to media interviews he has done in the past like this one ... he seems like the perfect candidate for the job. Well done Paradigm!

    Can't wait to hear the good news stories that will come out of this early access treatment.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.